ImmunoGen Inc IMGN:NASDAQ

Last Price$5.31Cboe Closing Price as of 4:00PM ET 8/10/22
Cboe Real-Time Quotes
Today's Change+0.04(0.76%)
Bid (Size)$5.03 (100)
Ask (Size)$5.74 (100)
Day Low / High$5.26 - 5.46
Volume1.6 M
 

View Biotechnology IndustryPeer Comparison as of 08/10/2022

 

ImmunoGen Inc ( NASDAQ )

Price: $5.31
Change: +0.04 (0.76%)
Volume: 1.6 M
4:00PM ET 8/10/2022
 
 

Rhythm Pharmaceuticals Inc ( NASDAQ )

Price: $21.47
Change: -1.18 (5.21%)
Volume: 1.4 M
4:00PM ET 8/10/2022
 
 

Cogent Biosciences Inc ( NASDAQ )

Price: $13.77
Change: +0.78 (6.00%)
Volume: 1.0 M
4:00PM ET 8/10/2022
 
 

Morphic Holding Inc ( NASDAQ )

Price: $33.10
Change: +2.09 (6.74%)
Volume: 185.3 K
3:46PM ET 8/10/2022
 
 

Deciphera Pharmaceuticals Inc ( NASDAQ )

Price: $17.17
Change: +0.23 (1.36%)
Volume: 574.1 K
4:00PM ET 8/10/2022
 

Read more news Recent News

Sector Update: Health Care Stocks Remain Lower Ahead of Friday's Close
3:36PM ET 7/29/2022 MT Newswires

Health care stocks remained marginally lower in late Friday trading, with the NYSE Health Care Index down about 0.7% and the SPDR Health Care Select Sector...

Sector Update: Health Care
3:27PM ET 7/29/2022 MT Newswires

Health care stocks remained marginally lower in late Friday trading, with the NYSE Health Care Index down about 0.6% and the SPDR Health Care Select Sector...

Update: ImmunoGen Q2 Net Loss Widens as Revenue Declines; Shares Fall
12:19PM ET 7/29/2022 MT Newswires

(Updates with stock movement in headline and last paragraph) ImmunoGen (IMGN) reported a Q2 net loss Friday of $0.24 per share, widening from a $0.15 loss...

-- Earnings Flash (IMGN) IMMUNOGEN Posts Q2 Revenue $14.2M
6:30AM ET 7/29/2022 MT Newswires

...

Company Profile

Business DescriptionImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. View company web site for more details
Address830 Winter Street
Waltham, Massachusetts 02451-1477
Phone+1.781.895.0600
Number of Employees296
Recent SEC Filing08/01/2022S-8
President, Chief Executive Officer & DirectorMark Joseph Enyedy
Chief Financial Officer & Senior Vice PresidentSusan Altschuller
Chief Medical Officer & Senior Vice PresidentAnna Berkenblit
Senior Vice President-Technical OperationsThomas Ryll

Company Highlights

Price Open$5.44
Previous Close$5.27
52 Week Range$3.10 - 7.77
Market Capitalization$1.2 B
Shares Outstanding220.7 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/04/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.69
Beta vs. S&P 500N/A
Revenue$53.4 M
Net Profit Margin-179.64%
Return on Equity-67.02%

Analyst Ratings as of 03/31/2022

Buy
7
Overweight
0
Hold
3
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset